Morningstar Investment Management’s Broadcom AVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.4M Hold
39,937
0.76% 21
2026
Q1
$12.4M Buy
39,937
+17,039
+74% +$5.61M 0.77% 21
2025
Q4
$7.92M Sell
22,898
-10,528
-31% -$3.76M 0.47% 41
2025
Q3
$11M Sell
33,426
-30,890
-48% -$9.48M 0.41% 47
2025
Q2
$17.7M Buy
64,316
+15,918
+33% +$3.46M 1.56% 15
2025
Q1
$8.1M Buy
48,398
+46,818
+2,963% +$9.91M 0.69% 21
2024
Q4
$366K Sell
1,580
-1,522
-49% -$282K 0.03% 146
2024
Q3
$566K Sell
3,102
-668
-18% -$107K 0.06% 129
2024
Q2
$605K Sell
3,770
-2,890
-43% -$405K 0.06% 114
2024
Q1
$883K Hold
6,660
0.1% 93
2023
Q4
$743K Sell
6,660
-1,520
-19% -$144K 0.09% 105
2023
Q3
$679K Sell
8,180
-2,800
-26% -$243K 0.09% 81
2023
Q2
$952K Hold
10,980
0.13% 66
2023
Q1
$704K Sell
10,980
-1,430
-12% -$86K 0.1% 49
2022
Q4
$694K Buy
+12,410
New +$622K 0.12% 49

Other funds holding AVGO

Morningstar Investment Management's AVGO Position: Q2 2026 in Review

Morningstar Investment Management held its Broadcom (AVGO) position steady in Q2 2026 at 39,937 shares worth $12.4M. The position accounts for 0.76% of the portfolio, ranked #21.

Morningstar Investment Management first reported a position in AVGO in Q4 2022 and has held it in 15 quarters since. The position peaked at $17.7M in Q2 2025. 2,032 funds tracked by Wall St. Rank hold AVGO as of Q2 2026.

  • Morningstar Investment Management held 39,937 shares of Broadcom worth $12.4M as of Q2 2026.
  • Morningstar Investment Management left its Broadcom share count unchanged in Q2 2026.
  • Broadcom made up 0.76% of Morningstar Investment Management's portfolio in Q2 2026, its #21 holding.
  • Morningstar Investment Management first reported a position in Broadcom in Q4 2022 and has held it in 15 quarters since.
  • Morningstar Investment Management's Broadcom position peaked at $17.7M in Q2 2025.
  • 2,032 funds tracked by Wall St. Rank held Broadcom as of Q2 2026.

Based on Morningstar Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.